It is currently Sun May 29, 2016 6:39 am
Biogen Idec, Neurimmune Therapeutics in JV to develop alzheimer's treatments
November 20, 2007: 02:30 AM EST
Biogen Idec (NASDAQ:BIIB) and Neurimmune Therapeutics AG announced they have entered into an agreement for the worldwide development and commercialization of novel, fully human antibodies for the treatment of Alzheimer's disease (AD).
The alliance will focus on the development of antibodies that bind ...
Total posts 232494 • Total topics 24863 • Total members 16017